Evaluation of Chronotype and Central Sensitization in Patients With Fibromyalgia Syndrome

Launched by OĞUZHAN KANDEMIR · Dec 26, 2023

Keywords

ClinConnect Summary

The clinical trial titled "Evaluation of Chronotype and Central Sensitization in Patients With Fibromyalgia Syndrome" is exploring how the natural sleep-wake patterns (called chronotypes) of women with fibromyalgia might relate to their pain and quality of life. Fibromyalgia is a condition that causes widespread pain and fatigue. The researchers want to understand if there is a connection between these sleep patterns and how intensely pain is felt, as well as how it affects daily activities and overall well-being.

To be eligible for this study, participants must be women aged between 18 and 65 who have been diagnosed with fibromyalgia for at least three months, according to specific guidelines. However, women with certain other health conditions, like neurological diseases, inflammation, or cancer, will not be able to participate. Those who join the study can expect to share information about their sleep habits and pain experiences, which will help researchers learn more about the relationship between sleep patterns and fibromyalgia symptoms. This research could lead to better treatments and support for those living with this challenging condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Being diagnosed according to ACR 2016 Fibromyalgia Syndrome Diagnostic criteria Continuing complaints for at least 3 months
• Exclusion Criteria:
• • Neurological and Inflammatory diseases Pregnancy Malignancy